IMO the strategy for setting up the US facility is the right...

IMO the strategy for setting up the US facility is the right direction.

Should result in increased US sales. As Archemy buyers will certainly feel more comfortable when they can see a US based manufacturing site, more easily see demonstrations and local supporting teams. Shows a real commitment for ongoing support of US customers. Rather than a small Australian based company with a US sales "outpost" and minimal supporting teams.

Will also allow AML3D, if Archemy sales are stalling a bit, to actively pursue some more contract manufacturing. Being based in US will allow quick turnaround given minimal transit time and build the technology's reputation. Some of the past contracts (eg. submarine parts) were for significant value and great to sustaining the business.

Also believe in the defence industry there are certain "classified" components which must be manufactured in US.

Still reflect that the company only has a market capitalisation of $16M. If they can find a sustainable path to profitability through Archemy support and contract work will be worth significantly more.